The agency is still unclear about where it will stand on clinical trial diversity, but companies are looking for answers and ...

Since the first days of the new Trump administration, the White House has handed down orders to ban work focused on diversity ...

"You don't fully understand whether sub-populations will benefit in the same way as those involved in the trials do." Campbell is an author of "Investigator Racial Diversity and Clinical Trial ...

IQVIA's research has been helped by a "dramatic increase" in diversity data collection in phase 2 and 3 trials in the past six years, which has provided a baseline against which progress can be ...

Clinical trials are the foundation of modern medicine, shaping the treatments and therapies that improve and save lives.

“You don’t fully understand whether sub-populations will benefit in the same way as those involved in the trials do.” Campbell is an author of “Investigator Racial Diversity and Clinical Trial ...

Spokespeople for Eli Lilly, Bristol Myers Squibb, Sanofi and Roche’s Genentech confirmed in emails to Fierce Biotech that their work on advancing clinical trial diversity remains ongoing.

and it is the responsibility of the researcher to build the trust needed to increase diversity in these trials, the panel agreed. Kwatra told the audience he often makes a point to have a personal ...

Modern medicine is a marvel, with previously unimaginable cures and treatments now widely available. Think of advanced medical devices such as implantable defibrillators that help regulate heart ...

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. While the executive order was most ...